<?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName art560.dtd?>
<?SourceDTD.Version 5.6.0?>
<?ConverterInfo.XSLTName elsevier2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<?FILEmeta_CSBJ1420 xml ?>
<?FILEmain xml ?>
<?FILEmain pdf ?>
<?FILEgr1 jpg ?>
<?FILEgr2 jpg ?>
<?FILEgr3 jpg ?>
<?FILEgr4 jpg ?>
<?FILEgr5 jpg ?>
<?FILEgr6 jpg ?>
<?FILEsi1 svg ?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Comput Struct Biotechnol J</journal-id>
    <journal-id journal-id-type="iso-abbrev">Comput Struct Biotechnol J</journal-id>
    <journal-title-group>
      <journal-title>Computational and Structural Biotechnology Journal</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2001-0370</issn>
    <publisher>
      <publisher-name>Research Network of Computational and Structural Biotechnology</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8897669</article-id>
    <article-id pub-id-type="pii">S2001-0370(22)00063-0</article-id>
    <article-id pub-id-type="doi">10.1016/j.csbj.2022.02.023</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Data Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>SDC: An integrated database for sex differences in cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au005">
        <name>
          <surname>Zhao</surname>
          <given-names>Long-Fei</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="af015" ref-type="aff">c</xref>
        <xref rid="af020" ref-type="aff">d</xref>
        <xref rid="af025" ref-type="aff">e</xref>
      </contrib>
      <contrib contrib-type="author" id="au010">
        <name>
          <surname>Zhang</surname>
          <given-names>Jin-Ge</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="af015" ref-type="aff">c</xref>
        <xref rid="af020" ref-type="aff">d</xref>
        <xref rid="af025" ref-type="aff">e</xref>
      </contrib>
      <contrib contrib-type="author" id="au015">
        <name>
          <surname>Qi</surname>
          <given-names>Feng-Yu</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="af015" ref-type="aff">c</xref>
        <xref rid="af020" ref-type="aff">d</xref>
        <xref rid="af025" ref-type="aff">e</xref>
      </contrib>
      <contrib contrib-type="author" id="au020">
        <name>
          <surname>Hou</surname>
          <given-names>Wei-Yan</given-names>
        </name>
        <xref rid="af030" ref-type="aff">f</xref>
      </contrib>
      <contrib contrib-type="author" id="au025">
        <name>
          <surname>Li</surname>
          <given-names>Yin-Rui</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="af015" ref-type="aff">c</xref>
        <xref rid="af020" ref-type="aff">d</xref>
        <xref rid="af025" ref-type="aff">e</xref>
      </contrib>
      <contrib contrib-type="author" id="au030">
        <name>
          <surname>Shen</surname>
          <given-names>Dan-Dan</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="af015" ref-type="aff">c</xref>
        <xref rid="af020" ref-type="aff">d</xref>
        <xref rid="af025" ref-type="aff">e</xref>
      </contrib>
      <contrib contrib-type="author" id="au035">
        <name>
          <surname>Zhao</surname>
          <given-names>Li-Juan</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="af015" ref-type="aff">c</xref>
        <xref rid="af020" ref-type="aff">d</xref>
        <xref rid="af025" ref-type="aff">e</xref>
      </contrib>
      <contrib contrib-type="author" id="au040">
        <name>
          <surname>Qi</surname>
          <given-names>Lin</given-names>
        </name>
        <email>ielqi@zzu.edu.cn</email>
        <xref rid="af030" ref-type="aff">f</xref>
        <xref rid="cor1" ref-type="corresp">⁎</xref>
      </contrib>
      <contrib contrib-type="author" id="au045">
        <name>
          <surname>Liu</surname>
          <given-names>Hong-Min</given-names>
        </name>
        <email>liuhm@zzu.edu.cn</email>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="af015" ref-type="aff">c</xref>
        <xref rid="af020" ref-type="aff">d</xref>
        <xref rid="af025" ref-type="aff">e</xref>
        <xref rid="cor1" ref-type="corresp">⁎</xref>
      </contrib>
      <contrib contrib-type="author" id="au050">
        <name>
          <surname>Zheng</surname>
          <given-names>Yi-Chao</given-names>
        </name>
        <email>yichaozheng@zzu.edu.cn</email>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="af015" ref-type="aff">c</xref>
        <xref rid="af020" ref-type="aff">d</xref>
        <xref rid="af025" ref-type="aff">e</xref>
        <xref rid="cor1" ref-type="corresp">⁎</xref>
      </contrib>
      <aff id="af005"><label>a</label>Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</aff>
      <aff id="af010"><label>b</label>State Key Laboratory of Esophageal Cancer Prevention &amp; Treatment, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</aff>
      <aff id="af015"><label>c</label>Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</aff>
      <aff id="af020"><label>d</label>Institute of Drug Discovery and Development, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</aff>
      <aff id="af025"><label>e</label>School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</aff>
      <aff id="af030"><label>f</label>School of Information Engineering, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>⁎</label>Corresponding authors at: Key Lab of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China (H.M. Liu and Y.C. Zheng). <email>ielqi@zzu.edu.cn</email><email>liuhm@zzu.edu.cn</email><email>yichaozheng@zzu.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>26</day>
      <month>2</month>
      <year>2022</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>26</day>
      <month>2</month>
      <year>2022</year>
    </pub-date>
    <volume>20</volume>
    <fpage>1068</fpage>
    <lpage>1076</lpage>
    <history>
      <date date-type="received">
        <day>1</day>
        <month>11</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>29</day>
        <month>1</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>24</day>
        <month>2</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 The Authors</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
      </license>
    </permissions>
    <abstract id="ab005">
      <p>Sex differences are evident in the incidence and mortality of diverse cancers. With the development of personalized approaches in cancer treatment, the impact of sex differences has not been systematically incorporated into preclinical and clinical cancer research. The molecular mechanisms underlying sex differences in cancer have not been elucidated. Here, we developed the first database of Sex Differences in Cancer (SDC), a web-based public database that integrates resources from multiple databases, including The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression Project (GTEx), UCSC Xena, Broad Institute Cancer Cell Line Encyclopedia (CCLE), Genomics of Drug Sensitivity in Cancer (GDSC). SDC contains 27 types of cancers, 6 types of molecular data, more than 10,000 donors, 977 cancer cell lines were used to analyze sex differences among cancers. It provides five main modules: Survival and phenotype, Molecular differences, Signatures and pathways, Therapy response, Download. Users can download the all the visualized results and raw data after analysis. Collectively, SDC is the first integrated database to analyze sex differences in cancer on the web server, which will strengthen our understanding of the role of sex in cancers. It is implemented in Shiny-server and freely available for public use at <ext-link ext-link-type="uri" xlink:href="http://sdc.anticancer.xyz" id="ir005"><underline>http://sdc.anticancer.xyz</underline></ext-link>.</p>
    </abstract>
    <kwd-group id="kg005">
      <title>Keywords</title>
      <kwd>Cancer</kwd>
      <kwd>Sex</kwd>
      <kwd>Differences</kwd>
      <kwd>Database</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="s0005">
    <label>1</label>
    <title>Introduction</title>
    <p id="p0005">Global cancer statistics <xref rid="b0005" ref-type="bibr">[1]</xref> (<ext-link ext-link-type="uri" xlink:href="https://gco.iarc.fr" id="ir010">https://gco.iarc.fr</ext-link>) and previous reports <xref rid="b0010" ref-type="bibr">[2]</xref>, <xref rid="b0015" ref-type="bibr">[3]</xref>, <xref rid="b0020" ref-type="bibr">[4]</xref>, <xref rid="b0025" ref-type="bibr">[5]</xref> showed that males have higher incidence, mortality, and poorer outcomes than females in the case of various types of cancer. Moreover, the male gender is an independent risk factor associated with distant metastasis and prognosis <xref rid="b0030" ref-type="bibr">[6]</xref>. Esophagogastric cancer <xref rid="b0035" ref-type="bibr">[7]</xref>, gastric cancer <xref rid="b0040" ref-type="bibr">[8]</xref>, <xref rid="b0045" ref-type="bibr">[9]</xref>, melanoma <xref rid="b0050" ref-type="bibr">[10]</xref>, and lung cancer <xref rid="b0055" ref-type="bibr">[11]</xref>, <xref rid="b0060" ref-type="bibr">[12]</xref> with sex bias have been focused. However, the molecular basis for these observed disparities is poorly understood.</p>
    <p id="p0010">While one study has suggested that sex differences in cancer may arise through the effect of circulating sex hormones <xref rid="b0065" ref-type="bibr">[13]</xref>, it has also been suggested that sex bias is derived from genetic and epigenetic differences arising from the influence of the sex chromosomes independent of sex hormones <xref rid="b0070" ref-type="bibr">[14]</xref>. For example, the X-linked lysine demethylase 6A and 5C, as well as Y-linked paralogs lysine demethylase 6C and 5D may be regulators of incidence and prognosis for sex-specific cancer <xref rid="b0050" ref-type="bibr">[10]</xref>, <xref rid="b0075" ref-type="bibr">[15]</xref>, <xref rid="b0080" ref-type="bibr">[16]</xref>. Moreover, the whole-genome study uncovered sex differences in mutation density, tumor evolution, and mutation signatures on the noncoding autosomal genome <xref rid="b0085" ref-type="bibr">[17]</xref>. Additionally, sex differences also play a role in distinct immunity as females have stronger innate and adaptive immune responses than males, reducing the risk of mortality due to cancer <xref rid="b0090" ref-type="bibr">[18]</xref>, <xref rid="b0095" ref-type="bibr">[19]</xref>; males are more likely to benefit from immune checkpoint inhibitors <xref rid="b0090" ref-type="bibr">[18]</xref>, <xref rid="b0100" ref-type="bibr">[20]</xref>. All these findings may be related to somatic mutation, immune microenvironment, and the immune system, but they need to be explored further.</p>
    <p id="p0015">Altogether, these studies underlined the prevalence of sex differences at a molecular level, in cancer and suggested that these differences are sex-specific but not lifestyle-dependent. However, in studies of cancer risk, prognosis, and therapeutic response, sex is still underexplored as a relevant variable. Additionally, these studies on sex effect were limited to individual genes, single molecular data types, and single cancer lineages, which lack association and are not attributed to signaling pathways. There is also a lack of exploration of sex differences in common molecular subtypes.</p>
    <p id="p0020">Therefore, building a public database is vital for collecting omics data and conducting integrative and in-depth analysis with sex differences. Here, we developed the SDC, the first web-based public database for accessing reproducible comprehensive differences analysis between the sexes that covers modules including phenotypic, molecular, and therapeutic response. These results can be quickly queried and presented in a customized manner via the website (<ext-link ext-link-type="uri" xlink:href="http://sdc.anticancer.xyz" id="ir015">http://sdc.anticancer.xyz</ext-link>), to utilize sex insights in the study of molecular oncology research and cancer therapy.</p>
  </sec>
  <sec id="s0010">
    <label>2</label>
    <title>Methods</title>
    <p id="p0025">Most of the analysis is run in R 3.6, and the code is open-sourced on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/longfei8533/SDC" id="ir020"><underline>https://github.com/longfei8533/SDC</underline></ext-link>) for reference and repetition.</p>
    <sec id="s0015">
      <label>2.1</label>
      <title>Data source</title>
      <p id="p0030">Biological data are mainly from TCGA, GTEx, CCLE and GDSC. Part of the data are from the collation and analysis results of UCSC Xena (<ext-link ext-link-type="uri" xlink:href="http://xena.ucsc.edu/" id="ir025">http://xena.ucsc.edu/</ext-link>). Cancer incidence and mortality data were manually downloaded from “CANCER TODAY” page at The Global Cancer Observatory (<ext-link ext-link-type="uri" xlink:href="https://gco.iarc.fr" id="ir030"><underline>https://gco.iarc.fr</underline></ext-link>). Overall Survival (OS), Progression-Free Interval (PFI), Disease-Free Interval (DFI), and Disease-Specific Survival (DSS) were defined and calculated in previous study <xref rid="b0105" ref-type="bibr">[21]</xref>, and the supplementary data was download for further analysis. Molecular subtype data were obtained from 26 published papers collected by UCSC Xena. Tumor microenvironment (TME) subtypes data obtained from previous study <xref rid="b0110" ref-type="bibr">[22]</xref>. Cancers with &lt;10 samples in one sex were excluded from analysis.</p>
    </sec>
    <sec id="s0020">
      <label>2.2</label>
      <title>Tumor purity</title>
      <p id="p0035">ESTIMATE is a method that uses gene expression profiles of 141 immune genes and 141 stromal genes to infer tumor cellularity <xref rid="b0115" ref-type="bibr">[23]</xref>. Tumor purity was added as a covariable to the model for correction during mRNA, miRNA, and copy number variation (CNV) analysis.</p>
    </sec>
    <sec id="s0025">
      <label>2.3</label>
      <title>Survival analysis and molecular subtypes</title>
      <p id="p0040">Survival analysis was performed with the Log-rank test. Fisher's exact test was performed to test the sex bias of different molecular subtypes.</p>
    </sec>
    <sec id="s0030">
      <label>2.4</label>
      <title>mRNA and miRNA</title>
      <p id="p0045">The package DESeq2 <xref rid="b0120" ref-type="bibr">[24]</xref> provides methods to test the differential expression of gene between female and male, and gives the P and log2FoldChange value based on a model using the negative binomial distribution. The tumor purity was added as a covariable to the model for correction. log2FoldChange &lt;0 indicates that the expression of gene is male-biased; log2FoldChange &gt;0 indicates that the expression of gene is female-biased. Tissue types in the GTEx database were converted into TCGA codes for easy comparison of sex differences between tumors and normal tissues.</p>
      <p id="p0050">The target genes of differentially expressed miRNA were predicted by TargetScanHuman <xref rid="b0125" ref-type="bibr">[25]</xref>. Counts per million (CPM) was computed and used to normalize mRNA and miRNA data. Then, the Pearson correlation coefficient was used to analyze the correlations.</p>
    </sec>
    <sec id="s0035">
      <label>2.5</label>
      <title>DNA methylation</title>
      <p id="p0055">The ChAMP package <xref rid="b0130" ref-type="bibr">[26]</xref> was used for the analysis of Illumina Methylation beadarray data (TCGA 450 k). Differential methylation probes, differential methylation regions and differential methylation were shown individually.</p>
    </sec>
    <sec id="s0040">
      <label>2.6</label>
      <title>Somatic mutation and copy number variation</title>
      <p id="p0060">Fisher’s exact test was performed on 2×2 contingency table generated from female and male cohorts to find differentially mutated genes. The total mutation burden was defined as the number of single nucleotide variant (SNV) and INDEL in the whole genome. Significance was calculated by Wilcox rank-sum test. In gene level, the Gistic2 copy number was used to estimate copy number differences between female and male. Further, CNV burdens including broad CNV scores (BCS), focal CNV scores (FCS) and global CNV scores (GCS), which were computed by CNApp <xref rid="b0135" ref-type="bibr">[27]</xref>. Finally, we recalculated copy number segments in the 1 M interval to obtain the region profile of CNV. Suppose there are <italic>N</italic> segments on the 1 M interval, with length <italic>L</italic> bases and copy number <italic>C</italic>.<disp-formula id="e0005"><mml:math id="M1" altimg="si1.svg"><mml:mrow><mml:mi mathvariant="italic">Average</mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>y</mml:mi><mml:mi>n</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:msubsup><mml:mfenced open="(" close=")"><mml:mrow><mml:mi>C</mml:mi><mml:mi>n</mml:mi><mml:mo>×</mml:mo><mml:mi>L</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:msubsup><mml:mi mathvariant="normal">Σ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>L</mml:mi><mml:mi>n</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p>
    </sec>
    <sec id="s0045">
      <label>2.7</label>
      <title>Tumor microenvironment</title>
      <p id="p0065">We used the IOBR R package <xref rid="b0140" ref-type="bibr">[28]</xref> to decode tumor microenvironment (TME) contexture using 7 published methodologies CIBERSORT <xref rid="b0145" ref-type="bibr">[29]</xref>, ESTIMATE <xref rid="b0115" ref-type="bibr">[23]</xref>, quanTIseq <xref rid="b0150" ref-type="bibr">[30]</xref>, TIMER <xref rid="b0155" ref-type="bibr">[31]</xref>, IPS <xref rid="b0160" ref-type="bibr">[32]</xref>, MCPCounter <xref rid="b0165" ref-type="bibr">[33]</xref>, EPIC <xref rid="b0170" ref-type="bibr">[34]</xref>. These methods are based on computational inference of gene expression profiles.</p>
    </sec>
    <sec id="s0050">
      <label>2.8</label>
      <title>Signatures and pathways</title>
      <p id="p0070">255 published signature gene sets were collected by IOBR, involving tumor microenvironment, tumor metabolism, m6A, exosomes, microsatellite instability, and tertiary lymphoid structure. We calculated the signature scores for all samples in the TCGA using three methodologies of ssGSEA, PCA and Z-score.</p>
      <p id="p0075">The PARADIGM algorithm integrates pathway, expression and copy number data to infer the activation of pathway features within a superimposed pathway network structure. This dataset is ssGSEA scores for 1387 constituent pathways, then Z transformed <xref rid="b0175" ref-type="bibr">[35]</xref>.</p>
    </sec>
    <sec id="s0055">
      <label>2.9</label>
      <title>Treatment response</title>
      <p id="p0080">Drug sensitivity data in cancer cell lines from the CCLE and GDSC were integrated, and these cancer cell lines were grouped by sex. Then, IC<sub>50</sub> of the individual drug to male or female were compared. Tumor Immune Dysfunction and Exclusion (TIDE) <xref rid="b0180" ref-type="bibr">[36]</xref> was used to predict the immunotherapy response from the gene expression profiles of cancer tissue samples. Conserved pan-cancer microenvironment subtypes can predict response to immunotherapy <xref rid="b0110" ref-type="bibr">[22]</xref>. Molecular profiles of cancer can be clustered into four distinct microenvironments termed (1) immune-enriched, fibrotic (IE/F); (2) immune-enriched, non-fibrotic (IE); (3) fibrotic (F); and (4) immune-depleted (D).</p>
    </sec>
  </sec>
  <sec id="s0060">
    <label>3</label>
    <title>Implementation and results</title>
    <sec id="s0065">
      <label>3.1</label>
      <title>The database overall design</title>
      <p id="p0085">The web was developed with R and Shiny following a modular and robust design. The data were preprocessed locally with some of the results loaded into memory for speed and another part stored in SQLite database (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). SDC uses a series of user-friendly interfaces to display results. Because of the Bootstrap and Shiny dependency, the interfaces are dynamic and interactive on a variety of devices with different screen sizes, and five main modules were provided, including (i) Survival and phenotype, (ii) Molecular differences, (iii) Signatures and pathways, (iv) Therapy response, (v) Download. All customized resulting images can be downloaded directly in PNG or PDF format. For “Download” module, all pre-processed data can be downloaded, most of which are saved as R data, and can be quickly loaded into the R environment by the R function “readRDS”. All the raw data used for analysis is also linked for easy access.<fig id="f0005"><label>Fig. 1</label><caption><p>The design of SDC.</p></caption><graphic xlink:href="gr1"/></fig></p>
    </sec>
    <sec id="s0070">
      <label>3.2</label>
      <title>Web interface and usage</title>
      <p id="p0090">The home page provides a module description and a quick jump (<xref rid="f0010" ref-type="fig">Fig. 2</xref>A). The global multi-cancer morbidity and mortality histogram is displayed at the bottom of the page, providing a quick and intuitive view of gender differences. The “Quick View” function is for the quickly selection of 1 in 27 tumor types for preview (<xref rid="f0010" ref-type="fig">Fig. 2</xref>B).<fig id="f0010"><label>Fig. 2</label><caption><p><bold>Home page function. A.</bold> Module descriptions and shortcuts are provided on the home page. Estimated age-standardized incidence and mortality rates (World) in 2020 for multiple types of cancers are displayed at the bottom of the page. <bold>B.</bold> Multiple analysis results can be quickly viewed by selecting one cancer type in the red box on the “Quick view” panel.</p></caption><graphic xlink:href="gr2"/></fig></p>
      <p id="p0095">For “Survival and phenotype” module, users can select different age stratifications and different endpoints to study differences in survival in specific cancers (<xref rid="f0015" ref-type="fig">Fig. 3</xref>A). Statistical analysis was performed on clinical characteristics of cancer patients and presented in the table (<xref rid="f0015" ref-type="fig">Fig. 3</xref>B). Findings from Fig. S1-S4 showed that there was no significant difference in survival between females and males in lung cancer, while, in esophageal and gastric cancers, females have a better prognosis than males).<fig id="f0015"><label>Fig. 3</label><caption><p><bold>Survival and phenotype module. A.</bold> Kaplan–Meier survival analysis between sexes. <bold>B.</bold> Patient clinical characteristics.</p></caption><graphic xlink:href="gr3"/></fig></p>
      <p id="p0100">Six data categories of analysis are included in the “Molecular differences” module. (i) For molecular subtypes, fisher's exact test results revealed sex-biased molecular subtypes (<xref rid="f0020" ref-type="fig">Fig. 4</xref>A). (ii) For mRNA, users can screen differentially expressed mRNAs under tumor purity correction. By inputting the minimum P value and fold change, users can further filter the highly reliable differential genes, and the results can be showed as a scatter plot (<xref rid="f0020" ref-type="fig">Fig. 4</xref>B). Data in mRNA level from normal GTEx tissues were calculated in the same way, so it is possible to discover which differential expression of gene are inherent before tumor development and which are caused after tumor development. Meanwhile, the results are displayed in the “Venn” panel (<xref rid="f0020" ref-type="fig">Fig. 4</xref>C). The detailed description of all genes can be jumped to GeneCard (<ext-link ext-link-type="uri" xlink:href="https://www.genecards.org/" id="ir035"><underline>https://www.genecards.org/</underline></ext-link>) with the aid of the hyperlink. (iii) miRNAs are filtered and presented in the same way. The score for target gene prediction of miRNA is shown in the table in the “Target” panel, and the correlation between genes and miRNAs can be further viewed on the “Correlation” panel (<xref rid="f0020" ref-type="fig">Fig. 4</xref>D). (iv) Differential DNA methylation in three levels, including CpG island, methylation regions and methylation blocks, were shown in the scatter plot and table. (v) Somatic mutation (SNV and INDEL) results that mainly include differences in mutation frequency of gene and total tumor mutation burden. (vi) For CNV, the Gistic2 copy number was used to estimated copy number differences between females and males in gene level. And, CNV burdens including BCS, FCS and GCS, which has been reported to be potential biomarkers for prognosis and immunotherapy <xref rid="b0185" ref-type="bibr">[37]</xref>, <xref rid="b0190" ref-type="bibr">[38]</xref>, were calculated with purity correction (<xref rid="f0020" ref-type="fig">Fig. 4</xref>E). Further, we recalculated copy number segments (log2(tumor/normal)) in the 1 M interval to obtain the region profile of CNV (<xref rid="f0020" ref-type="fig">Fig. 4</xref>F).<fig id="f0020"><label>Fig. 4</label><caption><p><bold>Molecular differences module. A.</bold> Sex bias of molecular subtypes. <bold>B.</bold> Differential expressed genes were filtered and shown as a scatter plot. <bold>C.</bold> Intersection of differential genes in tumor and normal tissue. <bold>D.</bold> Correlation between miRNA and target mRNA expression. <bold>E.</bold> The differences of CNV scores for broad, focal and global CNV burdens. <bold>F.</bold> Heatmap of the CNV region profile in all samples with sex annotation.</p></caption><graphic xlink:href="gr4"/></fig></p>
      <p id="p0105">For “Signatures and pathways” module, “Tumor microenvironment”, “Signatures” and “Pathways” three functions can be used. (i) Due to the importance of tumor-infiltrating immune cells in cancer treatment efficacy and patient prognosis <xref rid="b0195" ref-type="bibr">[39]</xref>, score for the tumor-infiltrating immune cells was calculated using 7 published methods <xref rid="b0115" ref-type="bibr">[23]</xref>, <xref rid="b0145" ref-type="bibr">[29]</xref>, <xref rid="b0150" ref-type="bibr">[30]</xref>, <xref rid="b0155" ref-type="bibr">[31]</xref>, <xref rid="b0160" ref-type="bibr">[32]</xref>, <xref rid="b0165" ref-type="bibr">[33]</xref>, <xref rid="b0170" ref-type="bibr">[34]</xref>. Different analysis was then performed based on the score and users can choose to display the exact P value on the box plot or a more intuitive symbol (<xref rid="f0025" ref-type="fig">Fig. 5</xref>A). (ii) In the “Signatures” panel, 255 tumor-associated signatures scores were calculated using ssGSEA, PCA and Z-score methods and compared between the sexes. Users can click on the two buttons at the bottom of the page to find the original article and signature genes (<xref rid="f0025" ref-type="fig">Fig. 5</xref>B). (iii) In the “Pathways” panel, different analysis was performed on pathway activity scores of 1387 constituent PARADIGM pathways.<fig id="f0025"><label>Fig. 5</label><caption><p><bold>Signatures and Pathways module. A.</bold> Analysis of differences in the tumor microenvironment. (i) is to select one of the seven published methods. (ii) can convert whether the plot is displayed as a p-value or asterisks. <bold>B.</bold> Analysis of the signal signature difference. (i) indicates that tumor-related signatures can be added and removed for presentation on the same plot. (ii) is three methods for signature calculation. (iii) is the two buttons to display the signature source and genes within the signature.</p></caption><graphic xlink:href="gr5"/></fig></p>
      <p id="p0110">For “Therapy response” module, “Chemotherapy response” and “Immunotherapy response” panels were included. In the “Chemotherapy response” panel, users can select one of three databases and then select a drug or target to explore the sensitivity of tumor cell lines to the drug. The results were presented as a box plot and volcano plot (<xref rid="f0030" ref-type="fig">Fig. 6</xref>A). In the “Immunotherapy response” panel, patients with a TIDE score &lt;0 were defined as positive responders to immunotherapy (<xref rid="f0030" ref-type="fig">Fig. 6</xref>B). Patients with IE and IE/F subtypes are more likely to benefit from immunotherapy, when using tumor microenvironment subtypes to predict immunotherapy response.<fig id="f0030"><label>Fig. 6</label><caption><p><bold>Therapy response module. A.</bold> Chemotherapy response results. <bold>B.</bold> Immunotherapy response results. The TIDE scores and response status between male and female were compared and displayed as box plot and histogram plot, respectively.</p></caption><graphic xlink:href="gr6"/></fig></p>
    </sec>
  </sec>
  <sec id="s0075">
    <label>4</label>
    <title>Future developments and discussion</title>
    <p id="p0115">As we have found that there were significant phenotypic differences between the two sexes that were disruptive to causal inferences, more covariates will be added to the model in the future or pre-treat the population with propensity score matching, so that to obtain a better and unbiased estimation. Our next plan is to integrate more samples and more types of biological data (e.g. immunotherapy patients, proteomics and epigenetics data) and mine relationships between modules (As shown in <xref rid="f0005" ref-type="fig">Fig. 1</xref>), the purple line represents the possible association) to provide more comprehensive and accurate insights. In the coming future, users’ data uploading function and analysis service will be provided to assess gender bias and generate reports.</p>
    <p id="p0120">Overall, SDC is the first comprehensive and user-friendly web database to study molecular differences, pathway differences, and therapeutic response differences between males and females in cancer. Based on this web database, we aim to integrate more comprehensive data and provide more evidence to explain the sex differences in cancer systematically, so that to facilitate antitumor studies and clinical practices. Fully understanding the mechanisms underlying sexual dimorphism in human cancers will be benefit to both basic cancer research and translational application for sex-specific diagnosis, prognosis, and treatment of cancer, which will contribute to personalized precision medicine.</p>
    <p id="p0125">
      <bold>Data and code availability</bold>
    </p>
    <p id="p0130">This study did not produce any raw data. Processed data, including reanalysis of published datasets are available in the download page at <underline>www.anticancer.xyz</underline>. Scripts used to generate results are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/longfei8533/SDC" id="ir040"><underline>https://github.com/longfei8533/SDC</underline></ext-link>.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Declaration of Competing Interest</title>
    <p id="p0135">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>
  </sec>
</body>
<back>
  <ref-list id="bi005">
    <title>References</title>
    <ref id="b0005">
      <label>1</label>
      <element-citation publication-type="journal" id="h0005">
        <person-group person-group-type="author">
          <name>
            <surname>Bray</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Ferlay</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Soerjomataram</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Siegel</surname>
            <given-names>R.L.</given-names>
          </name>
          <name>
            <surname>Torre</surname>
            <given-names>L.A.</given-names>
          </name>
          <name>
            <surname>Jemal</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>
        <source>CA Cancer J. Clin.</source>
        <volume>68</volume>
        <issue>2018</issue>
        <year>2018</year>
        <fpage>394</fpage>
        <lpage>424</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21492</pub-id>
        <pub-id pub-id-type="pmid">30207593</pub-id>
      </element-citation>
    </ref>
    <ref id="b0010">
      <label>2</label>
      <element-citation publication-type="journal" id="h0010">
        <person-group person-group-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Trynda</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Vold</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>J.H.</given-names>
          </name>
          <name>
            <surname>Harnois</surname>
            <given-names>D.M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sexual dimorphism in the incidence of human cancers</article-title>
        <source>BMC Cancer</source>
        <volume>19</volume>
        <year>2019</year>
        <fpage>684</fpage>
        <pub-id pub-id-type="doi">10.1186/s12885-019-5902-z</pub-id>
        <pub-id pub-id-type="pmid">31299933</pub-id>
      </element-citation>
    </ref>
    <ref id="b0015">
      <label>3</label>
      <element-citation publication-type="journal" id="h0015">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>J.S.</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>X.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries, The Lancet</article-title>
        <source>Global Health</source>
        <volume>6</volume>
        <year>2018</year>
        <fpage>e555</fpage>
        <lpage>e567</lpage>
        <pub-id pub-id-type="doi">10.1016/S2214-109X(18)30127-X</pub-id>
        <pub-id pub-id-type="pmid">29653628</pub-id>
      </element-citation>
    </ref>
    <ref id="b0020">
      <label>4</label>
      <element-citation publication-type="journal" id="h0020">
        <person-group person-group-type="author">
          <name>
            <surname>Radkiewicz</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Johansson</surname>
            <given-names>A.L.V.</given-names>
          </name>
          <name>
            <surname>Dickman</surname>
            <given-names>P.W.</given-names>
          </name>
          <name>
            <surname>Lambe</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Edgren</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>Sex differences in cancer risk and survival: A Swedish cohort study</article-title>
        <source>Eur. J. Cancer</source>
        <volume>84</volume>
        <year>2017</year>
        <fpage>130</fpage>
        <lpage>140</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ejca.2017.07.013</pub-id>
        <pub-id pub-id-type="pmid">28802709</pub-id>
      </element-citation>
    </ref>
    <ref id="b0025">
      <label>5</label>
      <element-citation publication-type="journal" id="h0025">
        <person-group person-group-type="author">
          <name>
            <surname>Innos</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Padrik</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Valvere</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Aareleid</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>Sex differences in cancer survival in Estonia: a population-based study</article-title>
        <source>BMC Cancer</source>
        <volume>15</volume>
        <year>2015</year>
        <fpage>72</fpage>
        <pub-id pub-id-type="doi">10.1186/s12885-015-1080-9</pub-id>
        <pub-id pub-id-type="pmid">25886269</pub-id>
      </element-citation>
    </ref>
    <ref id="b0030">
      <label>6</label>
      <element-citation publication-type="journal" id="h0030">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>H.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sex Disparities in the Clinical Characteristics, Synchronous Distant Metastasis Occurrence and Prognosis: A Pan-cancer Analysis</article-title>
        <source>J. Cancer</source>
        <volume>12</volume>
        <year>2021</year>
        <fpage>498</fpage>
        <lpage>507</lpage>
        <pub-id pub-id-type="doi">10.7150/jca.50536</pub-id>
        <pub-id pub-id-type="pmid">33391446</pub-id>
      </element-citation>
    </ref>
    <ref id="b0035">
      <label>7</label>
      <element-citation publication-type="journal" id="h0035">
        <person-group person-group-type="author">
          <name>
            <surname>Athauda</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Nankivell</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Langley</surname>
            <given-names>R.E.</given-names>
          </name>
          <name>
            <surname>Alderson</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Allum</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Grabsch</surname>
            <given-names>H.I.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)</article-title>
        <source>Eur. J. Cancer</source>
        <volume>137</volume>
        <year>2020</year>
        <fpage>45</fpage>
        <lpage>56</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ejca.2020.06.005</pub-id>
        <pub-id pub-id-type="pmid">32745964</pub-id>
      </element-citation>
    </ref>
    <ref id="b0040">
      <label>8</label>
      <element-citation publication-type="journal" id="h0040">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>Gender Differences in Gastric Cancer Survival: 99,922 Cases Based on the SEER Database</article-title>
        <source>J. Gastrointest. Surg.</source>
        <volume>24</volume>
        <year>2020</year>
        <fpage>1747</fpage>
        <lpage>1757</lpage>
        <pub-id pub-id-type="doi">10.1007/s11605-019-04304-y</pub-id>
        <pub-id pub-id-type="pmid">31346960</pub-id>
      </element-citation>
    </ref>
    <ref id="b0045">
      <label>9</label>
      <element-citation publication-type="journal" id="h0045">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>H.W.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>J.-H.</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>J.J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer</article-title>
        <source>Ann. Surg. Oncol.</source>
        <volume>23</volume>
        <year>2016</year>
        <fpage>4344</fpage>
        <lpage>4351</lpage>
        <pub-id pub-id-type="doi">10.1245/s10434-016-5448-0</pub-id>
        <pub-id pub-id-type="pmid">27469120</pub-id>
      </element-citation>
    </ref>
    <ref id="b0050">
      <label>10</label>
      <element-citation publication-type="journal" id="h0050">
        <person-group person-group-type="author">
          <name>
            <surname>Emran</surname>
            <given-names>A.A.</given-names>
          </name>
          <name>
            <surname>Nsengimana</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Punnia-Moorthy</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Schmitz</surname>
            <given-names>U.</given-names>
          </name>
          <name>
            <surname>Gallagher</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Newton-Bishop</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts</article-title>
        <source>Cancers (Basel)</source>
        <volume>12</volume>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.3390/cancers12082082</pub-id>
      </element-citation>
    </ref>
    <ref id="b0055">
      <label>11</label>
      <element-citation publication-type="journal" id="h0055">
        <person-group person-group-type="author">
          <name>
            <surname>Hanna</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Sugamori</surname>
            <given-names>K.S.</given-names>
          </name>
          <name>
            <surname>Bott</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>D.M.</given-names>
          </name>
        </person-group>
        <article-title>The impact of sex on hepatotoxic, inflammatory and proliferative responses in mouse models of liver carcinogenesis</article-title>
        <source>Toxicology</source>
        <volume>442</volume>
        <year>2020</year>
        <object-id pub-id-type="publisher-id">152546</object-id>
        <pub-id pub-id-type="doi">10.1016/j.tox.2020.152546</pub-id>
      </element-citation>
    </ref>
    <ref id="b0060">
      <label>12</label>
      <element-citation publication-type="journal" id="h0060">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X.-S.</given-names>
          </name>
        </person-group>
        <article-title>The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients' sex</article-title>
        <source>Int. J. Cancer</source>
        <volume>145</volume>
        <year>2019</year>
        <fpage>2840</fpage>
        <lpage>2849</lpage>
        <pub-id pub-id-type="doi">10.1002/ijc.32327</pub-id>
        <pub-id pub-id-type="pmid">30972745</pub-id>
      </element-citation>
    </ref>
    <ref id="b0065">
      <label>13</label>
      <element-citation publication-type="journal" id="h0065">
        <person-group person-group-type="author">
          <name>
            <surname>Clocchiatti</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Cora</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Dotto</surname>
            <given-names>G.P.</given-names>
          </name>
        </person-group>
        <article-title>Sexual dimorphism in cancer</article-title>
        <source>Nat. Rev. Cancer</source>
        <volume>16</volume>
        <year>2016</year>
        <fpage>330</fpage>
        <lpage>339</lpage>
        <pub-id pub-id-type="doi">10.1038/nrc.2016.30</pub-id>
        <pub-id pub-id-type="pmid">27079803</pub-id>
      </element-citation>
    </ref>
    <ref id="b0070">
      <label>14</label>
      <element-citation publication-type="journal" id="h0070">
        <person-group person-group-type="author">
          <name>
            <surname>Credendino</surname>
            <given-names>S.C.</given-names>
          </name>
          <name>
            <surname>Neumayer</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Cantone</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>Genetics and Epigenetics of Sex Bias: Insights from Human Cancer and Autoimmunity</article-title>
        <source>Trends Genet.</source>
        <volume>36</volume>
        <year>2020</year>
        <fpage>650</fpage>
        <lpage>663</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tig.2020.06.016</pub-id>
        <pub-id pub-id-type="pmid">32736810</pub-id>
      </element-citation>
    </ref>
    <ref id="b0075">
      <label>15</label>
      <element-citation publication-type="journal" id="h0075">
        <person-group person-group-type="author">
          <name>
            <surname>Tricarico</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Nicolas</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Golemis</surname>
            <given-names>E.A.</given-names>
          </name>
        </person-group>
        <article-title>X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis</article-title>
        <source>Clin. Cancer Res.</source>
        <volume>26</volume>
        <year>2020</year>
        <fpage>5567</fpage>
        <lpage>5578</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-20-1741</pub-id>
        <pub-id pub-id-type="pmid">32732223</pub-id>
      </element-citation>
    </ref>
    <ref id="b0080">
      <label>16</label>
      <element-citation publication-type="journal" id="h0080">
        <person-group person-group-type="author">
          <name>
            <surname>Dunford</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Weinstock</surname>
            <given-names>D.M.</given-names>
          </name>
          <name>
            <surname>Savova</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Schumacher</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>Cleary</surname>
            <given-names>J.P.</given-names>
          </name>
          <name>
            <surname>Yoda</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias</article-title>
        <source>Nat. Genet.</source>
        <volume>49</volume>
        <year>2017</year>
        <fpage>10</fpage>
        <lpage>16</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3726</pub-id>
        <pub-id pub-id-type="pmid">27869828</pub-id>
      </element-citation>
    </ref>
    <ref id="b0085">
      <label>17</label>
      <element-citation publication-type="journal" id="h0085">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>C.H.</given-names>
          </name>
          <name>
            <surname>Prokopec</surname>
            <given-names>S.D.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>R.X.</given-names>
          </name>
          <name>
            <surname>Yousif</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Schmitz</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Boutros</surname>
            <given-names>P.C.</given-names>
          </name>
        </person-group>
        <article-title>Sex differences in oncogenic mutational processes</article-title>
        <source>Nat. Commun.</source>
        <volume>11</volume>
        <year>2020</year>
        <fpage>4330</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-020-17359-2</pub-id>
        <pub-id pub-id-type="pmid">32859912</pub-id>
      </element-citation>
    </ref>
    <ref id="b0090">
      <label>18</label>
      <element-citation publication-type="journal" id="h0090">
        <person-group person-group-type="author">
          <name>
            <surname>Conforti</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Pala</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Bagnardi</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>de Pas</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Martinetti</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Viale</surname>
            <given-names>G.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis</article-title>
        <source>Lancet Oncol</source>
        <volume>19</volume>
        <year>2018</year>
        <fpage>737</fpage>
        <lpage>746</lpage>
        <pub-id pub-id-type="doi">10.1016/S1470-2045(18)30261-4</pub-id>
        <pub-id pub-id-type="pmid">29778737</pub-id>
      </element-citation>
    </ref>
    <ref id="b0095">
      <label>19</label>
      <element-citation publication-type="journal" id="h0095">
        <person-group person-group-type="author">
          <name>
            <surname>Irelli</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Sirufo</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>D'Ugo</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ginaldi</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>de Martinis</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Sex and Gender Influences on Cancer Immunotherapy Response</article-title>
        <source>Biomedicines</source>
        <volume>8</volume>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.3390/biomedicines8070232</pub-id>
      </element-citation>
    </ref>
    <ref id="b0100">
      <label>20</label>
      <element-citation publication-type="journal" id="h0100">
        <person-group person-group-type="author">
          <name>
            <surname>Castro</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Pyke</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>W.K.</given-names>
          </name>
          <name>
            <surname>Day</surname>
            <given-names>C.-P.</given-names>
          </name>
          <name>
            <surname>Alexandrov</surname>
            <given-names>L.B.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Strength of immune selection in tumors varies with sex and age</article-title>
        <source>Nat. Commun.</source>
        <volume>11</volume>
        <year>2020</year>
        <fpage>4128</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-020-17981-0</pub-id>
        <pub-id pub-id-type="pmid">32807809</pub-id>
      </element-citation>
    </ref>
    <ref id="b0105">
      <label>21</label>
      <element-citation publication-type="journal" id="h0105">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Lichtenberg</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Hoadley</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Poisson</surname>
            <given-names>L.M.</given-names>
          </name>
          <name>
            <surname>Lazar</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Cherniack</surname>
            <given-names>A.D.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics</article-title>
        <source>Cell</source>
        <volume>173</volume>
        <year>2018</year>
        <fpage>400</fpage>
        <lpage>416.e11</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2018.02.052</pub-id>
        <pub-id pub-id-type="pmid">29625055</pub-id>
      </element-citation>
    </ref>
    <ref id="b0110">
      <label>22</label>
      <element-citation publication-type="journal" id="h0110">
        <person-group person-group-type="author">
          <name>
            <surname>Bagaev</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kotlov</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Nomie</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Svekolkin</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Gafurov</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Isaeva</surname>
            <given-names>O.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Conserved pan-cancer microenvironment subtypes predict response to immunotherapy</article-title>
        <source>Cancer Cell</source>
        <volume>39</volume>
        <year>2021</year>
        <fpage>845</fpage>
        <lpage>865.e7</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ccell.2021.04.014</pub-id>
        <pub-id pub-id-type="pmid">34019806</pub-id>
      </element-citation>
    </ref>
    <ref id="b0115">
      <label>23</label>
      <element-citation publication-type="journal" id="h0115">
        <person-group person-group-type="author">
          <name>
            <surname>Yoshihara</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Shahmoradgoli</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Martínez</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Vegesna</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Torres-Garcia</surname>
            <given-names>W.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Inferring tumour purity and stromal and immune cell admixture from expression data</article-title>
        <source>Nat Commun</source>
        <volume>4</volume>
        <year>2013</year>
        <fpage>2612</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms3612</pub-id>
        <pub-id pub-id-type="pmid">24113773</pub-id>
      </element-citation>
    </ref>
    <ref id="b0120">
      <label>24</label>
      <element-citation publication-type="journal" id="h0120">
        <person-group person-group-type="author">
          <name>
            <surname>Love</surname>
            <given-names>M.I.</given-names>
          </name>
          <name>
            <surname>Huber</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Anders</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
        <source>Genome Biol</source>
        <volume>15</volume>
        <year>2014</year>
        <fpage>550</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
        <pub-id pub-id-type="pmid">25516281</pub-id>
      </element-citation>
    </ref>
    <ref id="b0125">
      <label>25</label>
      <element-citation publication-type="journal" id="h0125">
        <person-group person-group-type="author">
          <name>
            <surname>Agarwal</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>G.W.</given-names>
          </name>
          <name>
            <surname>Nam</surname>
            <given-names>J.-W.</given-names>
          </name>
          <name>
            <surname>Bartel</surname>
            <given-names>D.P.</given-names>
          </name>
        </person-group>
        <article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>
        <source>Elife</source>
        <volume>4</volume>
        <year>2015</year>
        <pub-id pub-id-type="doi">10.7554/eLife.05005</pub-id>
      </element-citation>
    </ref>
    <ref id="b0130">
      <label>26</label>
      <element-citation publication-type="journal" id="h0130">
        <person-group person-group-type="author">
          <name>
            <surname>Morris</surname>
            <given-names>T.J.</given-names>
          </name>
          <name>
            <surname>Butcher</surname>
            <given-names>L.M.</given-names>
          </name>
          <name>
            <surname>Feber</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Teschendorff</surname>
            <given-names>A.E.</given-names>
          </name>
          <name>
            <surname>Chakravarthy</surname>
            <given-names>A.R.</given-names>
          </name>
          <name>
            <surname>Wojdacz</surname>
            <given-names>T.K.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ChAMP: 450k Chip Analysis Methylation Pipeline</article-title>
        <source>Bioinformatics</source>
        <volume>30</volume>
        <year>2014</year>
        <fpage>428</fpage>
        <lpage>430</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btt684</pub-id>
        <pub-id pub-id-type="pmid">24336642</pub-id>
      </element-citation>
    </ref>
    <ref id="b0135">
      <label>27</label>
      <element-citation publication-type="journal" id="h0135">
        <person-group person-group-type="author">
          <name>
            <surname>Franch-Expósito</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Bassaganyas</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Vila-Casadesús</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hernández-Illán</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Esteban-Fabró</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Díaz-Gay</surname>
            <given-names>M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications</article-title>
        <source>Elife</source>
        <volume>9</volume>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.7554/eLife.50267</pub-id>
      </element-citation>
    </ref>
    <ref id="b0140">
      <label>28</label>
      <mixed-citation publication-type="other" id="h0140">D. Zeng, Z. Ye, G. Yu, J. Wu, Y. Xiong, R. Zhou, W. Qiu, N. Huang, L. Sun, J. Bin, Y. Liao, M. Shi, W. Liao, IOBR: Multi-omics Immuno-Oncology Biological Research to decode tumor microenvironment and signatures, 2020.</mixed-citation>
    </ref>
    <ref id="b0145">
      <label>29</label>
      <element-citation publication-type="journal" id="h0145">
        <person-group person-group-type="author">
          <name>
            <surname>Newman</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C.L.</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Gentles</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Y.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title>
        <source>Nat Methods</source>
        <volume>12</volume>
        <year>2015</year>
        <fpage>453</fpage>
        <lpage>457</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.3337</pub-id>
        <pub-id pub-id-type="pmid">25822800</pub-id>
      </element-citation>
    </ref>
    <ref id="b0150">
      <label>30</label>
      <element-citation publication-type="journal" id="h0150">
        <person-group person-group-type="author">
          <name>
            <surname>Finotello</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Mayer</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Plattner</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Laschober</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Rieder</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Hackl</surname>
            <given-names>H.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data</article-title>
        <source>Genome Med</source>
        <volume>11</volume>
        <year>2019</year>
        <fpage>34</fpage>
        <pub-id pub-id-type="doi">10.1186/s13073-019-0638-6</pub-id>
        <pub-id pub-id-type="pmid">31126321</pub-id>
      </element-citation>
    </ref>
    <ref id="b0155">
      <label>31</label>
      <element-citation publication-type="journal" id="h0155">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Q.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TIMER2.0 for analysis of tumor-infiltrating immune cells</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>48</volume>
        <year>2020</year>
        <fpage>W509</fpage>
        <lpage>W514</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa407</pub-id>
        <pub-id pub-id-type="pmid">32442275</pub-id>
      </element-citation>
    </ref>
    <ref id="b0160">
      <label>32</label>
      <element-citation publication-type="journal" id="h0160">
        <person-group person-group-type="author">
          <name>
            <surname>Charoentong</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Finotello</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Angelova</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Mayer</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Efremova</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Rieder</surname>
            <given-names>D.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade</article-title>
        <source>Cell Rep.</source>
        <volume>18</volume>
        <year>2017</year>
        <fpage>248</fpage>
        <lpage>262</lpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2016.12.019</pub-id>
        <pub-id pub-id-type="pmid">28052254</pub-id>
      </element-citation>
    </ref>
    <ref id="b0165">
      <label>33</label>
      <element-citation publication-type="journal" id="h0165">
        <person-group person-group-type="author">
          <name>
            <surname>Becht</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Giraldo</surname>
            <given-names>N.A.</given-names>
          </name>
          <name>
            <surname>Lacroix</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Buttard</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Elarouci</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Petitprez</surname>
            <given-names>F.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression</article-title>
        <source>Genome Biol</source>
        <volume>17</volume>
        <year>2016</year>
        <fpage>218</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-016-1070-5</pub-id>
        <pub-id pub-id-type="pmid">27765066</pub-id>
      </element-citation>
    </ref>
    <ref id="b0170">
      <label>34</label>
      <element-citation publication-type="journal" id="h0170">
        <person-group person-group-type="author">
          <name>
            <surname>Racle</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>de Jonge</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Baumgaertner</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Speiser</surname>
            <given-names>D.E.</given-names>
          </name>
          <name>
            <surname>Gfeller</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data</article-title>
        <source>Elife</source>
        <volume>6</volume>
        <year>2017</year>
        <object-id pub-id-type="publisher-id">e26476</object-id>
        <pub-id pub-id-type="doi">10.7554/eLife.26476</pub-id>
      </element-citation>
    </ref>
    <ref id="b0175">
      <label>35</label>
      <element-citation publication-type="journal" id="h0175">
        <person-group person-group-type="author">
          <name>
            <surname>Hoadley</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Yau</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Hinoue</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Wolf</surname>
            <given-names>D.M.</given-names>
          </name>
          <name>
            <surname>Lazar</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Drill</surname>
            <given-names>E.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer</article-title>
        <source>Cell</source>
        <volume>173</volume>
        <year>2018</year>
        <fpage>291</fpage>
        <lpage>304.e6</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2018.03.022</pub-id>
        <pub-id pub-id-type="pmid">29625048</pub-id>
      </element-citation>
    </ref>
    <ref id="b0180">
      <label>36</label>
      <element-citation publication-type="journal" id="h0180">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Wan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>P.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Large-scale public data reuse to model immunotherapy response and resistance</article-title>
        <source>Genome Med.</source>
        <volume>12</volume>
        <year>2020</year>
        <fpage>21</fpage>
        <pub-id pub-id-type="doi">10.1186/s13073-020-0721-z</pub-id>
        <pub-id pub-id-type="pmid">32102694</pub-id>
      </element-citation>
    </ref>
    <ref id="b0185">
      <label>37</label>
      <element-citation publication-type="journal" id="h0185">
        <person-group person-group-type="author">
          <name>
            <surname>Hieronymus</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Murali</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Tin</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Yadav</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Abida</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Moller</surname>
            <given-names>H.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death</article-title>
        <source>Elife</source>
        <volume>7</volume>
        <year>2018</year>
        <pub-id pub-id-type="doi">10.7554/eLife.37294</pub-id>
      </element-citation>
    </ref>
    <ref id="b0190">
      <label>38</label>
      <element-citation publication-type="journal" id="h0190">
        <person-group person-group-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>T.A.</given-names>
          </name>
          <name>
            <surname>Yarchoan</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Jaffee</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Swanton</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Quezada</surname>
            <given-names>S.A.</given-names>
          </name>
          <name>
            <surname>Stenzinger</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic</article-title>
        <source>Ann. Oncol.</source>
        <volume>30</volume>
        <year>2019</year>
        <fpage>44</fpage>
        <lpage>56</lpage>
        <pub-id pub-id-type="doi">10.1093/annonc/mdy495</pub-id>
        <pub-id pub-id-type="pmid">30395155</pub-id>
      </element-citation>
    </ref>
    <ref id="b0195">
      <label>39</label>
      <element-citation publication-type="journal" id="h0195">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Severson</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Pignon</surname>
            <given-names>J.-C.</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Novak</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Comprehensive analyses of tumor immunity: implications for cancer immunotherapy</article-title>
        <source>Genome Biol</source>
        <volume>17</volume>
        <year>2016</year>
        <pub-id pub-id-type="doi">10.1186/s13059-016-1028-7</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <ack id="ak005">
    <title>Acknowledgments</title>
    <p id="p0140">We thank TCGA, GTEx, UCSC Xena, CCLE, and GDSC teams. This work was supported by the National Key Research Program (No. 2018YFE0195100); the National Natural Science Foundation of China (No. 82020108030 and No. U21A20416); Science and Technology Innovation Talents of Henan Provincial Education Department (No. 19IRTSTHN001, China); Basic and Frontier Technology Research Project of Henan Province (No. 212102310313, China); Youth Supporting Program from Henan Province (No. 2021HYTP060); Basic Research of the Key Project of the High Education from the Education Department of Henan Province (No. 22ZX008, China).</p>
  </ack>
</back>
